Medicare Obesity Treatment: Trump Administration’s Decision
April 5, 2025
Medicare obesity treatment has become a crucial topic in the discussion about healthcare coverage for millions of Americans struggling with weight-related issues.Despite the demand for obesity medications like Wegovy and Zepbound, the Trump administration opted not to include these vital treatments in the Medicare program under Part D, leaving many without access to effective weight loss drugs.
Read more
Title X Funding Freeze: Impact on Healthcare Access
April 2, 2025
The recent Title X funding freeze has sparked significant concern among advocates for reproductive health and those relying on essential services.Under this federal family planning program, numerous clinics—including many affiliated with Planned Parenthood—procedurally depend on Title X support to provide vital services like birth control, cancer screenings, and STI testing.
Read more